Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genoil (GNOLF) EBT (2019 - 2025)

Genoil has reported EBT over the past 7 years, most recently at -$155119.0 for Q3 2025.

  • Quarterly EBT fell 6.1% to -$155119.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Sep 2025, down 29.41% year-over-year, with the annual reading at -$2.1 million for FY2024, 51.78% up from the prior year.
  • EBT was -$155119.0 for Q3 2025 at Genoil, up from -$221743.0 in the prior quarter.
  • Over five years, EBT peaked at -$143882.0 in Q1 2024 and troughed at -$2.5 million in Q1 2022.
  • The 5-year median for EBT is -$427717.0 (2022), against an average of -$702238.9.
  • Year-over-year, EBT plummeted 517.03% in 2022 and then soared 94.3% in 2024.
  • A 5-year view of EBT shows it stood at -$755601.0 in 2021, then skyrocketed by 35.03% to -$490923.0 in 2022, then plummeted by 139.08% to -$1.2 million in 2023, then tumbled by 36.93% to -$1.6 million in 2024, then skyrocketed by 90.35% to -$155119.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's EBT are -$155119.0 (Q3 2025), -$221743.0 (Q2 2025), and -$154992.0 (Q1 2025).